TAK-861 Shows Promise in Phase 2b Narcolepsy Type 1 Trial
TAK-861 demonstrated significant and sustained improvements in the treatment of narcolepsy type 1 in a phase 2b clinical trial.
Source: sleepreviewmag.com
Stay updated with breaking news from Toward Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TAK-861 demonstrated significant and sustained improvements in the treatment of narcolepsy type 1 in a phase 2b clinical trial.